Labiotech.eu

News and Trends 16 Aug 2016

How did Cancer Cell Therapy become reality?

Using the body’s own tools to eradicate cancers has been a dream of Medicine for quite some time. How did the field of immuno-oncology evolve into today’s Biotech hype? The near-miraculous results of immuno-oncology cell therapies have dominated news about cancer breakthroughs. Indeed, CAR-T is a game-changer and are at the forefront of the ways Biotech […]

August 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 16 Aug 2016

GSK Pioneers Money Back Guarantee for Biotech Treatments

The second-ever gene therapy to get European approval finally has a price tag. It will be sold at ‘only’ €594k, but with a twist – it has a money-back guarantee. Could this strategy finally get gene therapies some sales action? In May, GSK finally got European approval for a gene therapy, after sparking the resurgence […]

August 16, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Aug 2016

Gilead licenses Danish Bispecific antibodies for the next HIV Cure

As an add-on to their previously secretive partnership, Genmab is now licensing its bispecific antibodies for Gilead‘s pursuit of an HIV cure for as much as €248M. At the top of the Pyramid of European Biotech value, Genmab is one of the success stories in Copenhagen’s Biotech ecosystem. Its technology for innovative antibodies has allowed it […]

August 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 15 Aug 2016

These 3 Synbio Startups did a ‘perfect pitch’ at IndieBio’s Demo Day

On July 28th 2016, IndieBio EU, the world’s first biotech accelerator, held their demo day in the lovely surroundings of Cork City Gaol. On the night, 13 startups pitched their ideas and products in the hopes of securing investment to take their ideas to the next level. Firebreathers and a live band added the finishing touch to […]

August 15, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 12 Aug 2016

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

Moderna is taking Biotech investing to new heights, as it has now increased total fundraising&partnership cash to an unbelievable €1.34Bn ($1.5Bn). It can thank AstraZeneca, which is now adding €126M more to its investment. Amid dropping revenues and pipeline cuts, AstraZeneca remains steadily focused on innovation and Biotech. After all, this was the strategy CEO Pascal […]

August 12, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 12 Aug 2016

EntreChem is going Back to the Future of Drug Discovery

We leave the Netherlands with a smile after visiting FF Pharma in Utrecht this week. Once again, we depart to another part of Europe and this time we’re heading to the North of Spain. Oviedo, the main capital of the Spanish Asturias region, is our final destination and is also where EntreChem, our Biotech of the […]

August 12, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 11 Aug 2016

New First-in-Human trial for rare Hereditary Angioedema begins in the UK

A new drug by KalVista is starting a Phase I trial. The drug could become a preventive treatment for people suffering for hereditary angioedema, a rare genetic condition that can be life-threatening. Based in the Tetricus Science Park (UK), KalVista targets proteases that are involved in diseases. It develops small molecule inhibitors for plasma kallikrein, an enzyme involved […]

August 11, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 11 Aug 2016

This new Phase III Failure adds up to AstraZeneca’s Troubles

AstraZeneca’s oncology pipeline takes a hit, as one of its Phase III trials failed to meet its primary endpoint. The program targeted advanced non-small lung cancer. It looks like it’s up to immunotherapies now. Now struggling for a while, AstraZeneca has been refocusing on cancer and investing big in new candidates. The strategy hasn’t yet […]

August 11, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 10 Aug 2016

Why on Earth would someone order DNA on Amazon?

Yes, you can now add a customized genetic sequence to your shopping cart, thanks to a Biotech startup. But what would you need it for? Let’s say, you are buying some really cool Biotech reading material online. You can now head to the ‘Industrial & Scientific’ section of Amazon and get a GeneSlice with that. For […]

August 10, 2016 - 4 minutesmins - By Denise Neves Gameiro

News and Trends 9 Aug 2016

Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

Ablynx has disclosed ‘compelling’ results for its Phase IIb trial in rheumatoid arthritis. But it might have a hard time compelling AbbVie to pay €68M to continue the candidate’s development, as the grass is not as green as it seems… Ablynx‘s impressive list of big Pharma collaborations could soon need an update, as its $840 partnership with […]

August 9, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 9 Aug 2016

Yes, Biotech can help you win the Olympic Games of Rio

The world’s eyes are set on the 2016 edition of the Summer Olympics, which started in Rio de Janeiro last week. I had a look at how Biotech has been involved in the Olympics – and how it could define it in the future. The Summer Olympics of 2016 have been marked by its fair […]

August 9, 2016 - 5 minutesmins - By Denise Neves Gameiro

News and Trends 8 Aug 2016

The Brain’s Sleep Switch was just discovered, zZz …

Researchers from the University of Oxford have discovered how certain neurons control when we go to sleep. The biology behind it involves an ion channel that reacts to the ‘happy chemical’ dopamine, changing places in the neurons. Sleep is essential to health, with the Center for Disease Control even calling insufficient sleep a public health […]

August 8, 2016 - 3 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

How did Cancer Cell Therapy become reality?

GSK Pioneers Money Back Guarantee for Biotech Treatments

Gilead licenses Danish Bispecific antibodies for the next HIV Cure

These 3 Synbio Startups did a ‘perfect pitch’ at IndieBio’s Demo Day

mRNA Money-magnet increases its Pile of Cash to over €1.3Bn

EntreChem is going Back to the Future of Drug Discovery

New First-in-Human trial for rare Hereditary Angioedema begins in the UK

This new Phase III Failure adds up to AstraZeneca’s Troubles

Why on Earth would someone order DNA on Amazon?

Ablynx’ Best-In-Class Antibody might not be that ‘Compelling’ to Abbvie

Yes, Biotech can help you win the Olympic Games of Rio

The Brain’s Sleep Switch was just discovered, zZz …

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!